Clinical Trials Logo

Other Solid Cancers clinical trials

View clinical trials related to Other Solid Cancers.

Filter by:
  • None
  • Page 1

NCT ID: NCT03289962 Active, not recruiting - Colorectal Cancer Clinical Trials

A Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors

Start date: December 21, 2017
Phase: Phase 1
Study type: Interventional

This is a Phase 1a/1b, open-label, multicenter, global, dose-escalation study designed to evaluate the safety, tolerability, immune response, and pharmacokinetics of autogene cevumeran (RO7198457) as a single agent and in combination with atezolizumab (MPDL3280A, an engineered anti-programmed death-ligand 1 [anti-PD-L1] antibody).